Johns Hopkins Children's Center

Royal Farms Demonstrates Commitment to Community with $150,000 Donation to Johns Hopkins Children's Center

Retrieved on: 
Wednesday, March 13, 2024
Royal Farms, Health, Coin, Organization, Johns Hopkins Children's Center, Neurology, Cardiology, Partnership, Patient, Farm, Hope, Operation, Neonatology, Hospital

BALTIMORE, March 13, 2024 (GLOBE NEWSWIRE) -- Royal Farms, a leading convenience store chain known for its commitment to serving communities, proudly announces a generous donation of $150,000 to the Johns Hopkins Children's Center.

Key Points: 
  • BALTIMORE, March 13, 2024 (GLOBE NEWSWIRE) -- Royal Farms, a leading convenience store chain known for its commitment to serving communities, proudly announces a generous donation of $150,000 to the Johns Hopkins Children's Center.
  • Since 1994, Royal Farms has collected over $3 million in coins from spare change donated from customers and provided it to Johns Hopkins Children’s Center to show our dedication to supporting children's health and well-being in the community.
  • "Royal Farms is honored to support the incredible work being done at Johns Hopkins Children's Center," said Jeff Mengel, Vice President of Operations at Royal Farms.
  • "We are incredibly grateful for Royal Farms' generous donation and ongoing support," said Jennifer Phelps at Johns Hopkins Children's Center.

New England Journal of Medicine Publishes Phase III Data Showing Xolair Significantly Reduced Allergic Reactions Across Multiple Foods in People With Food Allergies

Retrieved on: 
Sunday, February 25, 2024
Teens, Women, Children, Men, Clinical Trials, Biotechnology, Health, Consumer, Pharmaceutical, Bangladesh Technical Education Board, AAAAI, Johns Hopkins Children's Center, Research, Food allergy, Hazelnut, NIH, FDA, Food, Immunoglobulin E, Rheumatology, NEJM, Risk, Annual general meeting, Safety, Roche, Milk, ROG, Fear, Patient, Medicine, Asthma, Face, American Academy, Pharmaceutical industry

Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials.

Key Points: 
  • Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials.
  • The U.S. Food and Drug Administration (FDA) recently approved the expanded use of Xolair in children and adults with IgE-mediated food allergies based on the OUtMATCH data.
  • “While allergic reactions to exposures are common and often severe, there have been limited treatment advancements for food allergy.
  • “The OUtMATCH study demonstrated that anti-IgE therapy increased most patients’ threshold for an allergic reaction.

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Retrieved on: 
Sunday, February 25, 2024
Bangladesh Technical Education Board, AAAAI, Johns Hopkins Children's Center, Research, Food allergy, Hazelnut, NIH, FDA, Immunoglobulin E, Rheumatology, NEJM, Life, Risk, Annual general meeting, Safety, Milk, Fear, Associate, Patient, Novartis, Asthma, Food, Face, American Academy, Pharmaceutical industry

Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials4.

Key Points: 
  • Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials4.
  • The US Food and Drug Administration (FDA) recently approved the expanded use of Xolair in children and adults with IgE-mediated food allergies based on the OUtMATCH data.
  • "While allergic reactions to exposures are common and often severe, there have been limited treatment advancements for food allergy.
  • The results of the OUtMATCH study showed that anti-IgE therapy could significantly reduce the occurrence of allergic reactions across multiple foods in the event of an accidental exposure."

FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies

Retrieved on: 
Friday, February 16, 2024
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, Infection, Allergy, Bangladesh Technical Education Board, AAAAI, Johns Hopkins Children's Center, Emergency, Hazelnut, NIAID, American Academy, Omalizumab, NIH, Friends, Food, Immunoglobulin E, News, Asthma, Anaphylaxis, FARE, Annual general meeting, Prevalence, Roche, Milk, ROG, AAFA, Patient, Family, Phase, Ageing, Education

People taking Xolair for food allergies should continue to avoid all foods they are allergic to (commonly referred to as “food allergen avoidance”).

Key Points: 
  • People taking Xolair for food allergies should continue to avoid all foods they are allergic to (commonly referred to as “food allergen avoidance”).
  • Immunoglobulin E (IgE)-mediated food allergies are the most common type and are typically characterized by the rapid onset of symptoms following exposure to certain food allergens.
  • Xolair is the first and only FDA-approved medicine to reduce allergic reactions in people with one or more food allergies.
  • About 3.4 million children and 13.6 million adults in the U.S. have been diagnosed with IgE-mediated food allergies, based on estimates for 2024.

FDA approves Xolair® (omalizumab) as first and only medicine for children and adults with one or more food allergies

Retrieved on: 
Friday, February 16, 2024
Infection, Allergy, Bangladesh Technical Education Board, AAAAI, Johns Hopkins Children's Center, Emergency, Food allergy, Hazelnut, NIAID, NIH, FDA, Friends, Food, Immunoglobulin E, News, Anaphylaxis, FARE, Annual general meeting, Prevalence, Milk, AAFA, Patient, Family, Medicine, Novartis, Asthma, Phase, Ageing, Education, American Academy

People taking Xolair for food allergies should continue to avoid all foods they are allergic to (commonly referred to as "food allergen avoidance").

Key Points: 
  • People taking Xolair for food allergies should continue to avoid all foods they are allergic to (commonly referred to as "food allergen avoidance").
  • Immunoglobulin E (IgE)-mediated food allergies are the most common type and are typically characterized by the rapid onset of symptoms following exposure to certain food allergens3.
  • Xolair is the first and only FDA-approved medicine to reduce allergic reactions in people with one or more food allergies.
  • "Given the growing prevalence of food allergies, this news offers hope to the many children and adults who may benefit from a new way to help manage their food allergies."

Royal Farms Partners With PepsiCo Again to Spread Holiday Cheer

Retrieved on: 
Monday, December 18, 2023
Associate, Partnership, The Salvation Army, Johns Hopkins Children's Center, Marketing, Royal Farms, Farm, Pepsi, Patient, Johns Hopkins, Environment, Hospital

“PepsiCo is happy to partner with Royal Farms and the Salvation Army to support local families during the holiday season,” said Pepsi Account Manager, Dorian Lopez.

Key Points: 
  • “PepsiCo is happy to partner with Royal Farms and the Salvation Army to support local families during the holiday season,” said Pepsi Account Manager, Dorian Lopez.
  • Royal Farms and Pepsi will contribute to the Christmas lunch at Johns Hopkins Children’s Center, providing families with Royal Farms cookies and Pepsi-supplied beverages.
  • Each of the 209 families under care at Johns Hopkins Children's Center will also receive a $100 Royal Farms gift card.
  • This partnership reflects our longstanding commitment to meaningful philanthropy and supporting our community," stated Frank Schilling, Marketing and Merchandising Director for Royal Farms.

Levy Konigsberg Files Lawsuit on Behalf of 37 Men Who Were Sexually Abused as Juveniles at Maryland's Charles H. Hickey, Jr. School

Retrieved on: 
Wednesday, December 13, 2023
CHS, Woman, Interest, Johns Hopkins Children's Center, Prevalence, Justice, American juvenile justice system, State, Counselor, Embarrassment, The Baltimore Sun, Rehabilitation, Child, CVA, Psychological abuse, Survivor, DJS, Private investigator, Tobacco

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Levy Konigsberg has filed a lawsuit against the State of Maryland, alleging that the Maryland Department of Juvenile Services ("DJS") failed to protect children from decades of sexual abuse at one of Maryland's oldest and most controversial juvenile detention centers, the Charles H. Hickey, Jr. School ("CHS"). The lawsuit, brought on behalf of 37 men who were abused as children at CHS, is the latest in a string of Maryland juvenile detention abuse lawsuits spearheaded by Levy Konigsberg.

Key Points: 
  • The lawsuit, brought on behalf of 37 men who were abused as children at CHS, is the latest in a string of Maryland juvenile detention abuse lawsuits spearheaded by Levy Konigsberg.
  • Instead, they were victims of a pattern of sexual abuse that goes back decades at the Hickey School.
  • The Baltimore Sun has covered Levy Konigsberg's recent lawsuits on behalf of nearly 50 men and women who had been sexually abused as children at Maryland's Cheltenham Youth Detention Center and Thomas J.S.
  • Levy Konigsberg represents over 200 survivors of sexual abuse at Maryland's juvenile detention facilities and plans to continue fighting tirelessly on their behalf.

Nemours Children's Health Names Delaware Valley Regional President

Retrieved on: 
Monday, October 30, 2023
Harvard Business School, Woman, Strategic planning, Nemours, Region, JD, Bar, Care New England, Albany Medical College, New York University Stern School of Business, Research, Johns Hopkins Children's Center, Boston Children's Hospital, Mumford, Nemours Children's Hospital, Delaware, Quality, Union University, Hospital, Butler Hospital, Nursing, Management, Delaware Valley, New York University

WILMINGTON, Del., Oct. 30, 2023 /PRNewswire/ -- Nemours Children's Health announced today that Mark Marcantano, JD, will join the organization as Regional President for Nemours Children's Delaware Valley.

Key Points: 
  • WILMINGTON, Del., Oct. 30, 2023 /PRNewswire/ -- Nemours Children's Health announced today that Mark Marcantano, JD, will join the organization as Regional President for Nemours Children's Delaware Valley.
  • He will report to Mark Mumford, Nemours Enterprise Chief Operating Officer (COO) for the multistate, multisite children's health system.
  • "Mark brings a perfect blend of both ambulatory and inpatient experience to the new role of Regional President for Nemours Children's Health, Delaware Valley," said Mumford.
  • "There is no more inspiring focus than the mission and vision at Nemours Children's Health to provide the highest quality, value-based pediatric healthcare necessary to create the healthiest generations of children," said Marcantano.

Global Medical Tent Market Outlook and Forecast 2023 - 2028: Growing Military Activities and Increasing Rescue Operations Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 4, 2023
Health, Hospitals, Aurora, Infection, Influenza and Other Respiratory Viruses, Boston Children's Hospital, COVID-19, Connecticut Children's Medical Center, Vaccine hesitancy, Children's Hospital, History, Child, Respiratory syncytial virus, Children's Hospital Colorado, National Guard, Federal Emergency Management Agency, Johns Hopkins Children's Center, Medical Center (TV series), RSV, Hospital, Patient, Tennessee–Bulgaria National Guard Partnership, LANCO, Growth, Virus, Birth control, Vaccine

The use of inflatable medical tents is rising in the military, owing to troops stationed worldwide and increasing military investments.

Key Points: 
  • The use of inflatable medical tents is rising in the military, owing to troops stationed worldwide and increasing military investments.
  • The global medical tent market is expected to rise considerably due to increased usage of tents in the military segment, medical emergencies, and rescue operations.
  • The global medical tent market is moderately competitive and is expected to offer significant growth opportunities for vendors during the forecast period.
  • Some key market participants operating in the global medical tent market include Liri Structure, Instent Industries, ZINGERLE GROUP, LANCO, and HDT Global.

Medical Tent Market - Global Outlook and Forecast 2023-2028: Increasing Demand for Negative Pressure Isolation Tents Boosts Sector

Retrieved on: 
Tuesday, March 7, 2023
Aurora, History, Snow, SARS, Tuberculosis, Johns Hopkins Children's Center, Nursing care plan, Boston Children's Hospital, Child, Patient, Decontamination, Measles, Maintenance, Influenza and Other Respiratory Viruses, Government, Respiratory syncytial virus, Infection, MERS, Cholera, COVID-19, Children's Hospital Colorado, Wind, Hospital, RSV, USD, Triage, Military personnel, Atmosphere, Static pressure, Ukrainians, Disaster, City, Ebola, Children's Hospital, Growth, Vaccine hesitancy, Non-governmental organization, Virus, Multi, NSR, Vaccine, Arms industry, Birth control, Pharmaceutical industry

The global medical tent market is expected to rise considerably due to increased usage of tents in the military segment, medical emergencies, and rescue operations.

Key Points: 
  • The global medical tent market is expected to rise considerably due to increased usage of tents in the military segment, medical emergencies, and rescue operations.
  • To remain competitive in the medical tent market, vendors have been focusing on meeting the challenges associated with traditional medical tents.
  • AKS Industries, UTILIS, Stretch Event Tents USA, and Instent Industries are some of the leading companies in the medical tent market offering negative pressure isolation tents.
  • Vendors are developing medical tents for various purposes, such as medical supplies storage, medical waste disposal tents, decontamination, and multipurpose tents.